We conclude that at least the following genes: ADA, ADA2, BTK, CTLA4, LRBA, NFKB1, NFKB2, PIK3CD, STAT3 and TNFRSF13B should always be considered in any custom panel design intended to be used as a diagnostic test for patients with complete (reduction of all major immunoglobulin isotypes) or selective antibody deficiency. This evidence concerns the gene TNFRSF13B and agammaglobulinemia.